MODINE MANUFACTURING CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MODINE MANUFACTURING CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Mar 31, 2016 | $1.35B | May 26, 2016 |
| FY2016 | Mar 31, 2015 | $1.50B | May 26, 2016 |
| FY2016 | Mar 31, 2014 | $1.48B | May 26, 2016 |
| FY2015 | Mar 31, 2013 | $1.38B | May 29, 2015 |
| FY2013 | Mar 31, 2012 | $1.58B | May 30, 2014 |
| FY2012 | Mar 31, 2011 | $1.45B | May 31, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.58B | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $2.41B | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $2.30B | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $2.05B | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $1.81B | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $472.90M | May 29, 2020 |
| FY2020 | Dec 31, 2019 | $473.40M | May 29, 2020 |
| FY2020 | Sep 30, 2019 | $500.20M | May 29, 2020 |
| FY2020 | Jun 30, 2019 | $529.00M | May 29, 2020 |
| FY2020 | Mar 31, 2019 | $556.70M | May 29, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $566.60M | May 24, 2018 |
| FY2018 | Dec 31, 2017 | $512.70M | May 24, 2018 |
| FY2018 | Sep 30, 2017 | $508.30M | May 24, 2018 |
| FY2018 | Jun 30, 2017 | $515.50M | May 24, 2018 |
| FY2018 | Mar 31, 2017 | $488.30M | May 24, 2018 |
| FY2018 | Dec 31, 2016 | $349.80M | May 24, 2018 |
| FY2018 | Sep 30, 2016 | $317.70M | May 24, 2018 |
| FY2018 | Jun 30, 2016 | $347.20M | May 24, 2018 |
| FY2016 | Mar 31, 2016 | $343.70M | May 26, 2017 |
| FY2016 | Dec 31, 2015 | $328.70M | May 26, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $643.80M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $525.60M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $389.40M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $309.30M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $293.40M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $74.90M | May 29, 2020 |
| FY2020 | Dec 31, 2019 | $73.50M | May 29, 2020 |
| FY2020 | Sep 30, 2019 | $75.70M | May 29, 2020 |
| FY2020 | Jun 30, 2019 | $83.40M | May 29, 2020 |
| FY2020 | Mar 31, 2019 | $91.60M | May 29, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $184.00M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $161.50M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $153.10M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $85.20M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | ($210.70M) | May 25, 2023 |
| FY2020 | Mar 31, 2020 | ($6.70M) | May 29, 2020 |
| FY2020 | Dec 31, 2019 | $1.20M | May 29, 2020 |
| FY2020 | Sep 30, 2019 | ($4.70M) | May 29, 2020 |
| FY2020 | Jun 30, 2019 | $8.00M | May 29, 2020 |
| FY2020 | Mar 31, 2019 | $6.30M | May 29, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $283.50M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $240.70M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $150.40M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $119.20M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | ($97.70M) | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $37.90M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $109.70M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $92.20M | May 29, 2020 |
| FY2019 | Mar 31, 2017 | $42.30M | May 23, 2019 |
| FY2018 | Mar 31, 2016 | $37.10M | May 24, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $34.90M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $42.00M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $44.00M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $50.30M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $46.30M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $59.50M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $69.80M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $65.80M | May 29, 2020 |
| FY2019 | Mar 31, 2017 | $64.40M | May 23, 2019 |
| FY2018 | Mar 31, 2016 | $61.10M | May 24, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $332.10M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $273.90M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $234.00M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $215.10M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $210.90M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $249.60M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $244.10M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $245.80M | May 29, 2020 |
| FY2019 | Mar 31, 2017 | $203.20M | May 23, 2019 |
| FY2018 | Mar 31, 2016 | $170.00M | May 24, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $213.30M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $214.60M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $107.50M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $11.50M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $149.80M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $57.90M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $103.30M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $124.20M | May 29, 2020 |
| FY2019 | Mar 31, 2017 | $41.70M | May 23, 2019 |
| FY2018 | Mar 31, 2016 | $72.40M | May 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $84.00M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $87.70M | May 21, 2025 |
| FY2025 | Mar 31, 2023 | $50.70M | May 21, 2025 |
| FY2024 | Mar 31, 2022 | $40.30M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $32.70M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $71.30M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $73.90M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $71.00M | May 29, 2020 |
| FY2019 | Mar 31, 2017 | $64.40M | May 23, 2019 |
| FY2018 | Mar 31, 2016 | $62.80M | May 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.92B | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $1.85B | May 21, 2025 |
| FY2024 | Mar 31, 2023 | $1.57B | May 22, 2024 |
| FY2023 | Mar 31, 2022 | $1.43B | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $1.28B | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $1.54B | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $1.54B | May 29, 2020 |
| FY2019 | Mar 31, 2018 | $1.57B | May 23, 2019 |
| FY2018 | Mar 31, 2017 | $1.45B | May 24, 2018 |
| FY2016 | Mar 31, 2016 | $920.90M | May 26, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $999.40M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $1.10B | May 21, 2025 |
| FY2024 | Mar 31, 2023 | $966.30M | May 22, 2024 |
| FY2023 | Mar 31, 2022 | $968.90M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $920.60M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $1.04B | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $996.90M | May 29, 2020 |
| FY2019 | Mar 31, 2018 | $1.07B | May 23, 2019 |
| FY2018 | Mar 31, 2017 | $1.03B | May 24, 2018 |
| FY2016 | Mar 31, 2016 | $538.20M | May 26, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $910.20M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $747.60M | May 21, 2025 |
| FY2024 | Mar 31, 2023 | $592.80M | May 22, 2024 |
| FY2023 | Mar 31, 2022 | $450.70M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $348.70M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $487.90M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $533.90M | May 29, 2020 |
| FY2019 | Mar 31, 2018 | $490.10M | May 23, 2019 |
| FY2018 | Mar 31, 2017 | $414.00M | May 24, 2018 |
| FY2016 | Mar 31, 2016 | $376.20M | May 26, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $233.90M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $230.90M | May 21, 2025 |
| FY2024 | Mar 31, 2023 | $165.60M | May 22, 2024 |
| FY2024 | Mar 31, 2022 | $168.10M | May 22, 2024 |
| FY2023 | Mar 31, 2021 | $170.70M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $166.10M | May 26, 2022 |
| FY2021 | Mar 31, 2019 | $168.50M | May 27, 2021 |
| FY2020 | Mar 31, 2018 | $173.80M | May 29, 2020 |
| FY2019 | Mar 31, 2017 | $165.10M | May 23, 2019 |
| FY2018 | Mar 31, 2016 | $15.80M | May 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $843.00M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $659.00M | May 21, 2025 |
| FY2024 | Mar 31, 2023 | $497.50M | May 22, 2024 |
| FY2023 | Mar 31, 2022 | $344.40M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $259.20M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $469.90M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $472.10M | May 29, 2020 |
| FY2019 | Mar 31, 2018 | $394.90M | May 23, 2019 |
| FY2018 | Mar 31, 2017 | $372.40M | May 24, 2018 |
| FY2016 | Mar 31, 2016 | $358.20M | May 26, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $71.60M | May 21, 2025 |
| FY2025 | Mar 31, 2024 | $60.10M | May 21, 2025 |
| FY2024 | Mar 31, 2023 | $67.10M | May 22, 2024 |
| FY2023 | Mar 31, 2022 | $45.20M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $37.80M | May 26, 2022 |
| FY2021 | Mar 31, 2020 | $70.90M | May 27, 2021 |
| FY2020 | Mar 31, 2019 | $41.70M | May 29, 2020 |
| FY2019 | Mar 31, 2018 | $39.30M | May 23, 2019 |
| FY2018 | Mar 31, 2017 | $34.20M | May 24, 2018 |
| FY2018 | Mar 31, 2016 | $68.90M | May 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Mar 31, 2016 | $125.40M | May 26, 2016 |
| FY2016 | Mar 31, 2015 | $125.20M | May 26, 2016 |
| FY2015 | Mar 31, 2014 | $125.50M | May 29, 2015 |
| FY2013 | Mar 31, 2013 | $126.90M | May 30, 2014 |
| FY2012 | Mar 31, 2012 | $136.30M | May 31, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 3 | May 21, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 21, 2025 |
| FY2025 | Mar 31, 2023 | 2 | May 21, 2025 |
| FY2024 | Mar 31, 2022 | 1 | May 22, 2024 |
| FY2023 | Mar 31, 2021 | (4) | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 29, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 29, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 29, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 29, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 29, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 3 | May 21, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 21, 2025 |
| FY2025 | Mar 31, 2023 | 2 | May 21, 2025 |
| FY2024 | Mar 31, 2022 | 1 | May 22, 2024 |
| FY2023 | Mar 31, 2021 | (4) | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 29, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 29, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 29, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 29, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 29, 2020 |